Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1888100Generated: October 26, 2026

Cyclohexanol → Cyclohexyl 2-(4-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperazin-1-yl)-1,3-thiazole-4-carboxylate

https://huagongshe.com/reaction/1888100

Reaction equation

Participants

RoleNameHCIDCharge
ReactantCyclohexanolHCID 7966—
Reactant1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 15908—
Reactant2-DimethylaminopyridineHCID 21885—
Reactant2-[4-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl]-1-piperazinyl]-4-thiazolecarboxylic acidHCID 67151088—
SolventWaterHCID 962—
SolventDichloromethaneHCID 6344—
ProductCyclohexyl 2-(4-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperazin-1-yl)-1,3-thiazole-4-carboxylateHCID 52920340—

Reaction Steps

At room temperature, cyclohexanol (82 mg), dimethylaminopyridine (10 mg) and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide (150 mg) are added to a solution of 2-(4-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperazin-1-yl)-1,3-thiazole-4-carboxylic acid (XXXIV-1, 300 mg) in dichloromethane (5 ml). The mixture is stirred overnight, and water is then added. The aqueous phase is separated off and extracted with ethyl acetate. The combined organic phases are dried with sodium sulphate. The solid is filtered off and the solvent is removed by distillation. The residue is purified chromatographically. This gives cyclohexyl 2-(4-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperazin-1-yl)-1,3-thiazole-4-carboxylate (45 mg, 12%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08501781B2
Source datasetuspto-grants-2013_08
ORD IDord-d5f56263ca1144fcbccf5900e9fbf50d
Source noteuspto-grants-2013_08